To mediate cytotoxicity, hIMB1636-LDP fusion protein must have the ability to bind the native antigen on cancer cells, and thus we first detected the expression levels of Trop2 in a variety of lung cancer and breast cancer cells. Here, TACSTD2 is linked to breast carcinoma.